Fingerprint
Dive into the research topics of 'Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer
J. Nemunaitis, T. Jahan, H. Ross, D. Sterman, D. Richards, B. Fox, D. Jablons, J. Aimi, A. Lin, K. Hege
Research output: Contribution to journal › Article › peer-review
144
Scopus
citations